2008

Abbasi NR, Yancovitz M, Gutkowicz-Krusin D, Panageas KS, Mihm MC, Googe P, King R, Prieto V, Osman I, Friedman RJ, Rigel DS, Kopf AW, Polsky D. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Archives of Dermatology 2008;144:469-474.

Abu-Rustum NR, Iasonos A, Zhou Q, Oke E, Soslow RA, Alektiar KM, Chi DS, Barakat RR. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? American Journal of Obstetrics and Gynecology 2008;198:457. Discussion 1-5.

Akin O, Sala E, Moskowitz CS, Ishill N, Soslow RA, Chi DS, Hricak H. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology 2008;248:511-517.

Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies. The American Journal of Surgical Pathology 2008;32:377-382.

Allen PJ, Reiner AS, Gonen M, Klimstra DK, Blumgart LH, Brennan MF, D'Angelica M, DeMatteo R, Fong Y, Jarnagin WR. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. Official Journal of the International Hepato Pancreato Biliary Association 2008;10:341-346.

Amar D, Desiderio DP, Heerdt PM, Kolker AC, Zhang H, Thaler HT. Practice patterns in choice of left double-lumen tube size for thoracic surgery. Anesthesia and Analgesia 2008; 106:379-383.

Ambrosini G, Seelman SL, Qin LX, Schwartz GK. The cyclin dependent kinase flavopiridol potentiates the effects of topoisomerase 1 poisons by suppressing Rad51 expression in p53-dependent manner. Cancer Research 2008;68:2312-2320.

Amin B, Nehal KS, Jungbluth AA, Zaidi B, Brady MS, Coit DC, Zhou Q, Busam KJ. Histologic distinction between benign subungual melanotic macule and malignant melanoma. The American Journal of Surgical Pathology 2008;32:835-843.

Ariyan C, Brady MS, Gonen M, Busam K, Coit D. Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma. Annals of Surgical Oncology 2008; [epub ahead of print].

Assimes TL, Olshen AB, Narasimhan B, Olshen RA. Associations among multiple markers and complex disease: models, algorithms, and applications. Advances In Genetics 2008;60:437-64. Review.

Bach PB. Cost sharing for health care-whose skin? Which game? New England Journal of Medicine 2008;358:411-413.

Bach PB. Do surgical quality gaps cause healthcare disparities? Medical Care 2008;46:889-892.

Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncology 2008;9:693-697.

Bach PB. Lung cancer screening. Journal of the National Comprehensive Cancer Network 2008; 6:271-275.

Bach PB. Over diagnosis in lung cancer: different perspectives, definitions, implications. Thorax 2008;63:298-300.

Bach PB. Response to "CT screening for lung cancer: update 2007". The Oncologist 2008;13:608-609; author reply 610-612.

Bach PB. Untreated patients in "CT screening for lung cancer: update 2007". The Oncologist 2008; 13: 1030-1032; author reply 1033.

Bach PB. "Paying doctors to ignore patients." The New York Times, July 24, 2008 opinion section.

Barbour AP, Jones M, Gönen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM. Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response. Annals of Surgical Oncology 2008 Jul 29. [Epub ahead of print]

Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, Gerogi A, Schumacher J, Schwarz M, Abou Jamra R, Hofels S, Propping P, Satagopan J, Detra-Wadleigh SD, Hardy J, McMahon FJ. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Molecular Psychiatry 2008; 13:197-207.

Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL. Variation of breast cancer risk among BRCA1/2 carriers. Journal of the American Medical Association 2008;299:194-201.

Begg CB. Commentary: Meta-analysis methods for diagnostic accuracy. Journal of Clinical Epidemiology 2008; 61: 1081-1082.

Bennett JJ, Schmidt CR, Klimstra DS, Grobmyer SR, Ishill NM, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Annals of Surgical Oncology 2008;15:1130-1136.

Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch C, Malone K, Reiner AS, Liang X, Haile R, Boice J, Bernstein JL. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer in the Women's Environmental Cancer and Radiation Epidemiology Study. American Journal of Epidemiology 2008; (in press).

Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD Jr, Shore RE; Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group, Bernstein JL. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. Journal of the National Cancer Institute 2008;100:32-40.

Black D, Levine DA, Nicoll L, Chou JF, Iasonos A, Brown CL, Sonoda Y, Chi DS, Leitao MM, Abu-Rustum NR, Ferguson SE, Barakat RR. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer. Gynecologic Oncology 2008;109:39-42.

Blinder V, Mazumdar M. Public policy issues in cancer rehabilitation. Principles and Practice of Cancer Rehabilitation, Editors: Michael Stubblefield, Michael O'Dell, Christian Custodio, and Teresa Fitzpatrick. Demos Medical Publishing, Woodbridge, CT, in press.

Breitbart W, Rosenfeld B, Gibson C, Kramer M, Li Y, Tomarken A, Nelson C, Pessin H, Esch J, Galietta M, Garcia N, Brechtl J, and Schuster M. Impact of treatment for depression on desire for hastened death in patients with advanced AIDS. Psychosomatics 2008; (in press).

BrintzenhofeSzoc KM, Levin TT, Li Y, Zabora J. The Prevalence of Mixed Anxiety-depression by Cancer Type. Psychosomatics 2008; (in press).

Brooks DD, Winawer SJ, Rex DK, Zauber AG, Kahi CJ, Smith RA, Levin B, Wender R: U.S. Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Colonoscopy surveillance after polypectomy and colorectal cancer resection. American Family Physician 2008;77:995-1002.

Caceres A, Zhou Q, Iasonos A, Gerdes H, Chi DS, Barakat RR. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecologic Oncology 2008;108:482-485.

Can AS, Bersot TP, Gönen M. Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults. Public Health Nutrition 2008; [epub ahead of print].

Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-1068.

Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S, Brennan MF. Why do patients with low-grade soft tissue sarcoma die? Annals of Surgical Oncology 2008;15:3550-3560.

Canter RJ, Qin LX, Maki RG, Brennan MF, Ladanyi M, Singer S. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clinical Cancer Research 2008;14:8191-8197.

Capanu M, Orlow I, Berwick M, Hummer A, Thomas D, Begg CB. The use of hierarchical models for estimating relative risks of individual genetic variants: an application to a study of melanoma. Statistics in Medicine 2008;27:1973-1992.

Capanu M, Presnell B. Misspecification tests for binomial and beta-binomial models. Statistics in Medicine 2008;27:2536-2554.

Castro-Malaspina H, Jabubowski AA, Papadopoulos EB, Boulad F, Young JW, Kernan NA, Perales MA, Small TN, Hsu K, Chiu M, Heller G, Collins NH, Jhanwar SC, van den Brink M, Nimer SD, O'Reilly RJ. Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. Biology of Blood and Marrow Transplanation 2008;14:458-468.

Chaudhury S, Auerbach AD, Kernan NA, Small TN, Prockop SE, Scaradavou A, Heller G, Wolden S, O'Reilly RJ, Boulad F. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi Anaemia. British Journal of Haematology 2008;140:644-655.

Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR, D'Angelica MI, Blumgart LH, DeMatteo RP. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. Journal of the American College of Surgeons 2008;206:281-291.

Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM. Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prevention Research 2008;1:21-31.

Chung A, Yu J, Stempel M, Patil SM, Cody H, Montgomery LM. Is the "10% rule" equally valid for all subsets of sentinel-node positive breast cancer patients? Annals of Surgical Oncology 2008;15:2728-2733.

Clarke JL, Iwamoto FM, Sul J, Panageas KS, Lassman AB, DeAngelis LM, Hormigo A, Nolan C, Gavrilovic I, Karimi S, Abrey LE. Randomized phase II trial of chemoradiotherapy followed by dose-dense versus metronomic temozolomide for newly diagnosed glioblastoma. Journal of Clinical Oncology 2008; (in press).

Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti, RA, Teraoka SN, Diep AT, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, The WECARE Study Collaborative Group and Bernstein JL. Variants in the ATM gene associated with a reduced risk of second primary breast cancer. Cancer Research 2008; 68:6486-6491.

Conin AM, Vickers AJ. Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study. BMC Medical Research Methodology 2008;8:75.

Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report. Value in Health 2008; [epub ahead of print].

Correa DD, Shi W,Thaler HT, Cheung AM, DeAngelis LM, Abrey LE. Longitudinal cognitive follow up in low grade gliomas. Journal of Neuro-oncology 2008;86:321-327.

D'Angelica M, Gönen M. Impact of margin width on outcome after resection of colorectal liver metastases. Annals of Surgery 2008;247:905-906.

Dahl D, Bohannan Z, Mo Q, Vannucci M, Tsai J. Knowledge based classification of amino acids based on torsion angle distributions. Journal of Molecular Biology 2008;378:749-758.

Dalal KM, Woo Y, Kelly K, Galanis C, Gonen M, Fong Y, Coit DG. Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction. Gastric Cancer 2008;11:206-213.

Dang C, D'Andrea G, Lake D, Sugarman S, Fornier M, Moynahan ME, Gilewski T, Hurria A, Mills N, Troso-Sandoval T, George R, Robson M, Dickler M, Smith K, Panageas KS, Norton L, Hudis CA. Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible. Clinical Breast Cancer 2008;8:418-424.

Dang C, Fornier M, Sugarman S, Troso-Sandoval T, Lake D, D'Andrea G, Seidman A, Sklarin N, Dickler M, Currie V, Gilewski T, Moynahan ME, Drullinsky P, Robson M, Wasserheit-Leiblich C, Mills N, Steingart R, Panageas K, Norton L, Hudis C. The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer. Journal of Clinical Oncology 2008;26:1216-1222.

Dash A, Lee P, Zhou Q, Jean-Gilles J, Taneja S, Satagopan J, Reuter V, Gerald W, Eastham J, Osman I. Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery. Urology 2008;72:641-646.

Dematteo RP, Gold JS, Saran L, Gonen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor. Cancer 2008;112:608-615.

Deng G, Rusch V, Vickers A, Malhotra V, Ginex P, Downey R, Bains M, Park B, Rizk N, Flores R, Yeung S, Cassileth B. Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. Journal of Thoracic and Cardiovascular Surgery. 2008;136:1464-1469.

Dickler MN, Rugo HS, Eberle CA, Brogi E, Caravelli JF, Panageas KS, Boyd J, Yeh B, Lake DE, Dang CT, Gilewski TA, Bromberg JF, Seidman AD, D'Andrea GM, Moasser MM, Melisko M, Park JW, Dancey J, Norton L, Hudis CA. A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. Clinical Cancer Research 2008;14:7878-7883.

Diefenbach CS, Gnjatic S, Sabbatini P, Aghajanian C, Hensley ML, Spriggs DR, Iasonos A, Lee H, Dupont B, Pezzulli S, Jungbluth AA, Old LJ, Dupont J. Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. Clinical Cancer Research 2008;14:2740-2748.

Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D'Angelica M, DeMatteo RP, Blumgart LH, O'Reilly EM. Gallbladder cancer (GBC): 10 year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). Journal of Surgical Oncology 2008;98:485-489.

Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O'Reilly EM. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Annals of Oncology 2008;19:86-91.

Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer 2008;113:1025-1031.

Elkin EB, Ishill N, Riley GF, Bach PB, Gonen M, Begg CB, Schrag D. Disenrollment from medicare managed care among beneficiaries with and without a cancer diagnosis. Journal of the National Cancer Institute 2008;100:1013-1021.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Intrahepatic cholangiocarcinoma: rising frequency improved survival and determinants of outcome after resection. Annuals of Surgery 2008;248:84-96.

Endo I, House MG, Klimstra DS, Gonen M, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Annals of Surgical Oncology 2008;15:2104-2112.

Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. The Oncologist 2008;13:911-920.

Fahy BN, D'Angelica M, DeMatteo RP, Blumgart LH, Weiser MR, Ostrovnaya I, Gonen M, Jarnagin WR. Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention. Annals of Surgical Oncology 2008;[epub ahead of print].

Feldman DR, Kondagunta GV, Schwartz L, Patil S, Ishill N, DeLuca J, Russo P, Motzer RJ. Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma. Clinical Genitourinary Cancer 2008;6:25-30.

Ferrone CR, Brennan MF, Gonen M, Coit DG, Fong Y, Chung S, Tang L, Klimstra D, Allen PJ. Pancreatic adenocarcinoma: the actual 5-year survivors. Journal of Gastrointestinal Surgery 2008;12:701-706.

Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Haile RW, the WECARE Study Collaborative Group and Bernstein JL. Oral contraceptives, post-menopausal hormones and risk of asynchronous bilateral breast cancer: the WECARE Study Group. Journal of Clinical Oncology 2008; 26:1411-1418.

Flynn LW, Park J, Patil SM, Cody HS 3rd, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. Journal of the American College of Surgeons 2008;206:616-621.

Forslund A, Zeng A, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman D, Barany F, Paty PB. MDM2 gene amplification is correlated to tumor progression but not to presence of SNP309 or TP53 mutational status in primary colorectal cancers. Molecular Cancer Research 2008;6:205-211.

Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick KE, Faulkner S, Zauber AG, Olson SH. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiology, Biomarkers & Prevention 2008; (in press).

Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF. Detection of circulating tumor cells in patients with urothelial cancer. Annals of Oncology 2008;[epub ahead of print].

Gaudet MM, Chanock S, Dunning A, Driver K, Brinton LA, Lissowska J, Peplonska B, Pharoah P, Garcia-Closas M. HSD17B1 genetic variants and hormone receptor-defined breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2008;17:2766-2772.

Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. International Journal of Cancer 2008;(in press).

Gaudet MM, Lacey JV Jr, Lissowska J, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M. Genetic variation in CYP17 and endometrial cancer risk. Human Genetics 2008;123:155-162.

Ghosh P, Gönen M. Bayesian modeling of multivariate average bioequivalence. Statistics in Medicine 2008;27:2402-2419.

Gignac GA, Morris MJ, Heller G, Schwartz LH, Scher HI. Assessing outcomes in prostate cancer clinical trials: a twenty-first century tower of Babel. Cancer 2008;113:966-974.

Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P, Kosarin K, Olsh A, Bergeron J, Ellis NA, Klein RJ, Clark AG, Norton L, Dean M, Boyd J, Offit K. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proceedings of the National Academy of Sciences of the United States of America USA 2008;105:4340-4345. Epub 2008 Mar 7.

Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y, DeMatteo RP, Blumgart LH, D'Angelica M. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Annals of Surgery 2008;247:109-117.

Gonen M. Area between curves: what you see is not what you get. Journal of Clinical Oncology 2008;26:2236; author reply 2236-2237.

Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW, Eastham JA, Scardino PT, Scher HI, Tickoo SK, Reuter VE, Gerald WL. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Research 2008; (in press).

Greco C, Nehmeh SA, Schoder H, Gonen M, Raphael B, Stambuk HE, Humm JL, Larson SM, Lee NY. Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer. American Journal of Clinical Oncology 2008;31:439-445.

Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, Nafa K, Riedel ER, Hsu M, Pao W, Miller VA, Ladanyi M. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clinical Cancer Research 2008;14:5731-5734.

Hoppe BS, Moskowitz CH, Filippa DA, Moskowitz CS, Kewalramani T, Zelenetz AD, Yahalom J. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity. Journal of Clinical Oncology 2008;26:1858-1864. Erratum in: Journal of Clinical Oncology 2008;26:4053.

Hoppe BS, Moskowitz CH, Zhang Z, Maragulia JC, Rice RD, Reiner AS, Hamlin PA, Zelenetz AD, Yahalom J. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma. Bone Marrow Transplantation 2008;(in press).

Houldsworth J, Petlakh M, Olshen AB, Chaganti RS. Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response. Leukemia Lymphoma 2008;49:2170-2180.

House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, Gonen M, Olson SH, Kurtz RC, Brennan MF, Allen PJ. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. Journal of Gastrointestinal Surgery 2008;12:270-278.

Hubbard K, Steinberg ML, Hill H, Orlow I. Mitochondrial DNA deletions in skin from melanoma patients. Ethnicity & Disease 2008; 18:S2-38-43.

Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. Journal of Clinical Oncology 2008;26:1364-1370. Review.

Iasonos A, Wilton AS, Riedel ER, Seshan VE, Spriggs DR. A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies. Clinical Trials 2008;5:465-477.

Ito H, Are C, Gonen M, D'Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Annals of Surgery 2008;247:994-1002.

Iwamoto FM, Reiner AS, Nayak L, Panageas KS, Elkin EB, Abrey LE. Importance of histology and grading in older glioma patients. Annals of Neurology 2008, (in press).

Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE. Patterns of care in elderly glioblastoma patients. Annals of Neurology 2008;64:628-634.

Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Kast WM, Hoos A, Elispot Proficiency Panel of the CVC Immune Assay Working Group. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunology Immunotherapy 2008;57:303-315.

Jarnagin WR, Gonen M, Kaithel SK, Fong Y, D'Angelica MI, DeMatteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Annals of Surgery 2008;248:360-369.

Jathavedam A, Feldman DR, Ishill N, Turkula S, Patil S, Bosl GJ, Motzer RJ, Weinstock DM. Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors. Biology of Blood and Marrow Transplantation 2008;14:595-600.

Jhawer M, Coit D, Brennan M, Qin LX, Gonen M, Klimstra D, Tang L, Kelsen DP, Shah MA. Perineural invasion following preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. American Journal of Clinical Oncology 2008 (in press).

Juretska M, Hensley ML, Tew W, Konner J, Aghajanian C, Leitao M, Iasonos A, Soslow R, Park K, Sabbatini P. A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission. European Journal of Gynaecolgoical Oncology 2008;29:568-572.

Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, van den Brink MR. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2008;[epub ahead of print].

Kattan MW, Gönen M. The prediction philosophy in statistics. Urologic Oncology 2008;26:316-319.

Kattan MW, Gönen M, Jarnagin WR, Dematteo R, D'Angelica M, Weiser M, Blumgart LH, Fong Y. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Annals of Surgery 2008;247:282-287.

Kemeny N, Capanu M, D'Angelica M, Jarnagin W, Haviland D, Dematteo R, Fong Y. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Annals of Oncology 2008, (in press).

Kim TD, Terwey TH, Zakrzewski JL, Suh D, Kochman AA, Chen ME, King CG, Borsotti C, Grubin J, Smith OM, Heller G, Liu C, Murphy GF, Alpdogan O, van den Brink MR. Organ-derived dendritic cells have differential effects on alloreactive T cells. Blood 2008;111:2929-2940.

King V, Vaze AA, Moskowitz CS, Smith LJ, Ginsberg MS. D-dimer assay to exclude pulmonary embolism in high-risk oncologic population: correlation with CT pulmonary angiography in an urgent care setting. Radiology 2008;247:854-861.

Kissane D, Li Y. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial. Cancer 2008; 112:443-444.

Klein EA, Bianco FJ, Serio AM, Eastham JA, Kattan MW, Pontes JE, Vickers AJ, Scardino PT. Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. Journal of Urology 2008;179:2212-2216.

Klein EA, Kattan M, Stephenson A, Vickers A. How many lymphadenectomies does it take to cure one patient? European Urology 2008;53:13-15.

Klimek VM, Fircanis S, Maslak P, Guernah I, Baum M, Wu N, Panageas K, Wright JJ, Pandolfi PP, Nimer SD. Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide(romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes. Clinical Cancer Research 2008;14:826-832.

Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008;112:2384-2392.

Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J, Chaganti RS. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer 2008;47:43-55.

Kreisl TN, Panageas KS, Elkin EB, Deangelis LM, Abrey LE. Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma. Leukemia Lymphoma 2008;49:1710-1716.

Ku GY, Ilson DH, Schwartz LH, Capanu M, O'Reilley E, Shah MA, Kelsen DP, Schwartz GK. Phase II trial of sequential paclitaxel and one hour infusion bryostatin-1 in patients with advanced esophageal cancer. Cancer Chemotherapy and Pharmacology 2008;62:875-880.

Kudo S, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Vieth M, Jass JR, Hurlstone PD. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointestinal Endoscopy 2008;68(4 Suppl):S3-47. Review.

Kurihara N, Fan K, Thaler HT, Yang K, Lipkin M. Effect of a Western-style diet fortified with increased calcium and vitamin D on mammary gland of C57BL/6 mice. Journal of Medicinal Food 2008; 11:201-206.

Lamanna N, Jurcic JG, Noy A, Maslak P, Gencarelli AN, Panageas KS, Heaney ML, Brentjens RJ, Golde DW, Scheinberg DA, Zelenetz AD, Weiss MA. Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. Journal of Clinical Oncology 2008;[epub ahead of print].

Langholz B, Thomas DC, Stovall M, Smith SA, Boice JD Jr, Shore RE, Bernstein L, Lynch CF, Zhang X, Bernstein JL, The WECARE Study Group. Statistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the WECARE study of asynchronous contralateral breast cancer. Biometrics 2008; [epub ahead of print]

Lansdorp-Vogelaar I, van Ballegooijen M, Boer R, Zauber A, Habbema JDF. A novel hypothesis on the sensitivity of FOBT. Results of a joint analysis of three randomized controlled trials. Cancer 2008; (in press).

Landsdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, Habbema JDF. Individualizing colonoscopy screening by gender and race. Gastrointestinal Endoscopy 2008; (in press).

Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Journal of the National Cancer Institute 2008;100:773-783.

Levin TT, Li Y, Weiner JM, Lewis F, Bartell A, Piercy J, Kissane DW: How do-not-resuscitate orders are utilized in cancer patients: timing relative to death and communication-training implications. Palliative and Supportive Care 2008; 6341-348.

Levy O, Deangelis LM, Filippa DA, Panageas KS, Abrey LE. Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer 2008;112:151-156.

Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nature Reviews Cancer 2008;8:268-278. Review. Erratum in Nature Reviews Cancer 2008;8:403.

Lipoff JB, Scope A, Dusza SW, Marghoob AA, Oliveria SA, Halpern AC. Complex dermoscopic pattern: a potential risk marker for melanoma. British Journal of Dermatology 2008;158:821-824.

Lissowska J, Gaudet MM, Brinton LA, Peplonska B, Sherman M, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M. Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status. Breast Cancer Research Treatment 2008;107:113-117.

Maithel Sk, Maloney S, Winston C, Gonen M, D'Angelica MI, DeMatteo RP, Jarnagin WR, Brennan MF, Allen PJ. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Annals of Surgical Oncology 2008;15:3512-3520.

Makker V, Abu-Rustum NR, Alektiar KM, Aghajanian CA, Zhou Q, Iasonos A, Hensley ML. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma. Gynecologic Oncology 2008;111:249-254.

Marks JL, Broderick S, Zhou Q, Chitale D. Li AR, Zakowski MF, Kris MG, Rusch VW, Azzoli CG, Seshan VE, Ladanyi M, Pao W. Prognostic and therapeutic implications of EGFR and KRAS mutation in resected lung adenocarcinoma. Journal of Thoracic Oncology 2008;3:111-116.

Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA. Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU International 2008;101:1217-1222.

Mazaheri Y, Shukla-Dave A, Hricak H, Fine SW, Zhang J, Inurrigarro G, Moskowitz CS, Ishill NM, Reuter VE, Touijer K, Zakian KL, Koutcher JA. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Radiology 2008;246:480-488.

McLaughlin SA, Ochoa-Frongia LM, Patil SM, Cody HS, Sclafani LM. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. Journal of American College of Surgeons 2008; 206: 76-82.

Mellemkjær L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale A, Stovall M, Langholz B, Bernstein L, Lynch, CF, Malone KE, Haile R, Andersson M, Thomas DC, Concannon P, Capanu M, Boice Jr. JD, The WECARE Study Collaborative Group, Bernstein JL. Risk for contralateral breast cancer among carriers of CHEK2*1100delC: a population-based multi-center case-control study. British Journal of Cancer 2008;98:728-733.

Meltzer LJ, Steinmiller E, Simms S, Grossman M, The CCCT, Li Y. Staff engagement during complex pediatric medical care: The role of patient, family, and treatment variables. Patient Education and Counseling 2008; [epub ahead of print].

Miglioretti DL, Rutter CM, Bradford SC, Zauber AG, Kessler LG, Feuer EJ, Grossman DC. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Medical Care 2008;46(9 Suppl 1):S91-6.

Miller VA, Riely GJ, Zakowski MF, Li AR, Patel JD, Heelan RT, Kris MG, Sandler AB, Carbone DP, Tsao A, Herbst RS, Heller G, Ladanyi M, Pao W, Johnson DH. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib. Journal of Clinical Oncology 2008;26:1472-1478.

Miyagawa T, Gogiberidze G, Serganova I, Cai S, Balatoni JA, Thaler HT, Ageyeva L, Pillarsetty N, Finn RD, Blasberg RG. Imaging of HSV-tk reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. Journal of Nuclear Medicine 2008;49:637-648.

Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy. Annals of Surgical Oncology 2008;15:2206-2214.

Moskowitz CS, Jia X, Schwartz LH, Gönen M. A simulation study to evaluate the impact of the number of lesions measured on response assessment. European Journal of Cancer 2008; [epub ahead of print].

Moskowitz CS, Seshan VE, Riedel ER, Begg CB. Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data. Statistics in Medicine 2008;27:3191-3208.

Neuman HB, Elkin EB, Guillem JG, Paty PB, Weiser MR, Wong D, Temple LK. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: A decision analysis. Disease of the Colon and Rectum 2008; (in press).

Neuman HB, Patel A, Ishill N, Hanlon C, Brady MS, Halpern AC, Houghton A, Coit DG. A single-institution validation of the AJCC staging system for stage IV melanoma. Annals of Surgical Oncology 2008;15:2034-2041.

Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, Smith SM, Mertens AC, Henderson TO, Friedman DL, Leisenring WM, Robison LL. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 2008 (in press).

Oliveria SA, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M,

Bishop M, Heneghan MK, Halpern AC. Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count. American Journal of Epidemiology 2008[epub ahead of print].

Olshen AB, Gold B, Lohmueller KE, Struewing JP, Satagopan J, Stefanov SA, Eskin E, Kirchhoff T, Lautenberger JA, Klein RJ, Friedman E, Norton L, Ellis NA, Viale A, Lee CS, Borgen PI, Clark AG, Offit K, Boyd J. Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC Genetics 2008;9:14.

Olson S, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K, Faulkner S, Tommasi D, Egan D, Roy P, Wilcox H, Asya A, Modica I, Asad H, Soslow R, Zauber AG. Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control 2008;19:955-963.

Orlow I, Park BJ, Mujumdar U, Patel H, Siu-Lau P, Clas BA, Downey R, Flores R, Bains M, Rizk N, Dominguez G, Jani J, Berwick M, Begg CB, Kris MG, Rusch VW. DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. Journal of Clinical Oncology 2008;26:3560-3566.

Ostrovnaya I, Seshan VE, Begg CB. Comparison of properties of tests for assessing tumor clonality. Biometrics 2008;64:1018-1022.

Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ, Reuter VE, Scardino PT, Shen MM, Aronow BJ, Vickers AJ, Gerald WL, Abate-Shen C. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Research 2008;68:2132-2144.

Panageas KS: Random versus fixed effects. Encyclopedia of Medical Decision Making 2008, (in press).

Pandit-Taskar N, O'Donoghue JA, Morris MJ, Wills EA, Schwartz LH, Gonen M, Scher HI, Larson SM, Divgi CR. Antibody mass escalation study in patients with castration-resistant prostate cancer using 111InJ591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy. Journal of Nuclear Medicine 2008;49:1066-1074.

Paoluzzi L, Gönen M, Bhagat G, Furman RR, Gardner JR, Scotto L, Gueorguiev VD, Heaney ML, Manova K, O'Connor OA. The BH3-only mimetic ABT-737 synergizes the anti-neoplastic activity of proteasome inhibitors in lymphoid malignancies. Blood 2008; [epub ahead of print].

Paoluzzi L, Gönen M, Gardner JR, Mastrella J, Yang D, Holmlund J, Sorensen M, Leopold L, Manova K, Marcucci G, Heaney ML, O' Connor OA.Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. Blood 2008; [epub ahead of print].

Park J, Linde K, Manheimer E, Molsberger A, Sherman K, Smith C, Sung J, Vickers A, Schnyer R. The status and future of acupuncture clinical research. Journal of Alternative and Complementary Medicine 2008;14:871-881.

Patel PH, Kondagunta GV, Schwartz L, Ishill N, Bacik J, DeLuca J, Russo P, Motzer RJ. Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma. Investigational New Drugs 2008;26:273-276.

Perales MA, Yuan J, Powel S, Gallardo HF, Rasalan TS, Gonzalez C, Manukian G, Wang J, Zhang Y, Chapman PB, Krown SE, Livingston PO, Ejadi S, Panageas KS, Engelhorn ME, Terzulli SL, Houghton AN, Wolchok JD. Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma. Molecular Therapy 2008;16:2022-2029.

Qin LX. An integrative analysis of microRNA and mRNA expression - a case study. Cancer Informatics 2008;6:369-379.

Qin LX, Satagopan JM. Normalization method for transcription studies of heterogeneous samples: Simultaneous array normalization and identification of equivalent expression. Statistical Application is Genetics and Molecular Biology 2008; (in press).

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Diseases of the Colon and Rectum 2008;51:503-507.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 2008;113:57-64.

Ragupathi G, Yeung KS, Leung PC, Lee M, Lau CB, Vickers A, Hood C, Deng G, Cheung NK, Cassileth B, Livingston P. Evaluation of widely consumed botanicals and immunological adjuvants. Vaccine 2008;26:4860-4865.

Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro-Oncology 2008;10:199-207.

Rathkopf D, Carducci MA, Morris MJ, Slovin SF, Eisenberger MA, Pili R, Denmeade SR, Kelsen M, Curley T, Halter M, Collins C, Fleisher M, Heller G, Baker SD, Scher HI. Phase II trial of docetaxel with rapid androgen cycling for progressive non-castrate prostate cancer. Journal of Clinical Oncology 2008;26:2959-2965.

Rietschel P, Wolchok JD, Krown S, Gerst S, Jungbluth A, Busam K, Smith K, Orlow I, Panageas K, Chapman PB. Phase II study of extended dose temozolomide in patients with melanoma. Journal of Clinical Oncology 2008;26:2299-2304.

Rimner A, Brennan MF, Zhang Z, Singer S, Alektiar KM. Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh. Cancer 2008;(in press).

Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Diseases of the Colon and Rectum 2008;51:147-153.

Rossner Jr P, Gammon MD, Zhang Y, Terry MB, Hibshoosh H, Memeo L, Mansukhani M, Long C, Garbowski G, Agrawal M, Kalra TS, Gaudet MM, Teitelbaum ST, Neugut A, Santella RM. Mutations in p53, p53 protein overexpression and breast cancer survival. Journal of Cell and Molecular Medicine 2008;(in press).

Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Bell P, Tomas JA, Neugut AI, Santella RM, Gammon MD. Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environmental Research 2008;(in press).

Salz T, Sandler RS. The effect of hospital and surgeon volume on outcomes for rectal cancer surgery. Clinical Gastroenterology and Hepatology 2008; 6:1185-1193.

Sawai A, Chandarlapaty S, Greulich H, Gonen M, Ye Q, Arteaga CL, Sellers W, Rosen N, Solit DB. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Cancer Research 2008;68:589-596.

Scher HI, Halabi S, Tannock I, Morris M, Carducci M, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Heller G, Basch E, Kelly WK, Figg W, Small EJ, Beer TM, Sternberg C, Wilding G, Martin A, Hussain M. Design and endpoints of phase 2 trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the prostate cancer clinical trials working group (PCWG2). Journal of Clinical Oncology 2008;26:1148-1159.

Schmidt CR, Gerdes H, William GH, Zucker E, Zhou Q, Riedel E, Jaques DP, Markowitz AJ, Coit DG, Schattner MA. Palliation for malignant gastric outlet obstruction: a prospective quality of life study. Gastrointestinal Endoscopy 2008;67:AB251.

Scope A, Marghoob AA, Dusza SW, Satagopan JM, Agero AL, Benvenuto-Andrade C, Lieb JA, Weinstock MA, Oliveria SA, Geller AC, Halpern AC. Dermoscopic patterns of naevi in fifth grade children of the Framingham school system. British Journal of Dermatology 2008;158:1041-1049.

Secin FP, Jiborn T, Bjartell AS, Fournier G, Salomon L, Abbou CC, Haber GP, Gill IS, Crocitto LE, Nelson RA, Cansino Alcaide JR, Martínez-Piñeiro L, Cohen MS, Tuerk I, Schulman C, Gianduzzo T, Eden C, Baumgartner R, Smith JA, Entezari K, van Velthoven R, Janestschek G, Serio AM, Vickers AJ, Touijer K, Guillonneau B. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. European Urology 2008;53:134-145.

Shen R, Chinnaiyan AM, Ghosh D. Pathway analysis reveals functional convergence of gene expression profiles in breast cancer. BMC Medical Genomics 2008;27:1:28.

Shen R, Ghosh D, Taylor JM. Modeling intra-tumor protein expression heterogeneity in tissue microarray experiments. Statistics in Medicine 2008;27:1944-1959.

Shen R, Taylor JM, Ghosh D. Reconstructing tumor-wise protein expression in tissue microarray studies using a Bayesian cell mixture model. Bioinformatics 2008;24:2880-2886.

Shia J, Klimstra DS, Nitzkorski JR, Low PS, Gonen M, Landmann R, Weiser MR, Franklin WA, Prendergast FG, Murphy L, Tang LH, Temple L, Guillem JG, Wong WD, Paty PB. Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Human Pathology 2008;39:498-505.

Sofocleous CT, Nascimento RG, Petrovic LM, Klimstra DS, Gonen M, Brown KT, Brody LA, Covey Am, Thornton RH, Fong Y, Solomon SB, Schwartz LH, DeMatteo RP, Getrajdman GI. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 2008;249:364-374.

Solit DB, Osman I, Polsky D, Panageas KS, Daud A, Goydos JS, Teitcher J, Wolchok JD, Germino FJ, Krown SE, Coit D, Rosen N, Chapman PB. Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma. Clinical Cancer Research 2008;14:8302-8307.

Steinberg AG, Bain L, Ewing R, Li Y. Meeting the public's health information needs: a plain language website outreach project: to reaching underserved parents of deaf children. Health Communication 2008; (in press).

Steinberg ML, Hubbard K, Utti C, Clas B, Hwang BJ, Hill HZ, Orlow I. Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients. Photochemistry and Photobiology 2008; (in press).

Steyerberg EW, Vickers AJ. Decision curve analysis: a discussion. Medical Decision Making 2008;28:146-9.

Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M., Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Reiner A, Thomas D. C., WECARE Study Collaborative Group, Bernstein JL. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Journal of Radiation Oncology, Biology and Physics 2008; 72:1021-1030.

Sugarman S, Wasserheit C, Hodgman E, Coglianese M, D'Alassandro A, Fournier M, Troso-Sandoval T, D'Andrea G, Drullinsky P, Lake D, George R, Mills N, Moynahan M, Smith J, Panageas K, Norton L, Hudis C. A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. Breast Cancer Research and Treatment 2008; [epub ahead of print].

Sun L, Zhang Z. A class of transformed mean residual life models under right censoring. Journal of the American Statistical Association 2008;(in press).

Swartz MD, Mo Q, Murphy ME, Lupton JR, Turner ND, Hong MY, Vannucci M. Bayesian variable selection in clustering high dimensional data with substructure. Journal of Agricultural, Biological and Environmental Statistics 2008;13:407-423.

Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI,Cody HS 3rd. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. Journal of Clinical Oncology 2008;26:1803-1809.

Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, Touijer K. Renal cell carcinoma in young and old patients--is there a difference? Journal of Urology 2008;180:1262-1266; discussion 1266.

Touijer K, Eastham JA, Secin FP, Romero Otero J, Serio A, Stasi J, Sanchez-Salas R, Vickers A, Reuter VE, Scardino PT, Guillonneau B. Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. Journal of Urology 2008;179:1811-7.

Touijer K, Secin FP, Cronin Am, Katz D, Bianco F, Vora K, Reuter V, Vickers AJ, Guillonneau B. Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. European Urology 2008; [epub ahead of print].

Traina TA, Poggesi I, Robson M, Asnis A, Duncan BA, Heerdt A, Dang C, Lake D, Moasser M, Panageas K, Borgen P, Norton L, Hudis C, Dickler MN. Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer. Breast Cancer Research and Treatment 2008;111:377-388.

Traina TA, Theodoulou M, Feigin F, Patil SM, Tan KL, Edwards C, Dugan U, Norton L, Hudis C. Phase I study of a novel capecitabine schedule based upon the Norton-Simon mathematical model in patients with metastatic breast cancer. Journal of Clinical Oncology 2008; 26: 1797-1802.

Tran W, Serio AM, Raj GV, Dalbagni G, Vickers AJ, Bochner BH, Herr H, Donat SM. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. Journal of Urology 2008;179:96-100.

Tse AN, Klimstra DS, Gonen M, Shah M, Sheikh T, Sikowski R, Carvajal R, Mui J, Tipian C, O'Reilly E, Chung K, Maki R, Lefkowitz R, Brown K, Manova-Todorava K, Wu N, Egorin MJ, Kelsen D, Schwartz GK. A phase I dose-escalation study of irinotecan in combination with 17-allylamino 17-demethoxygeldanamycin in patients with solid tumors. Clinical Cancer Research 2008;14:6704-6711.

Ulmert D, Cronin AM, Björk T, O'Brien MF, Scardino PT, Eastham JA, Becker C, Berglund G, Vickers AJ, Lilja H. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study. BMC Medicine 2008;6:6.

Ulmert D, Serio AM, O'Brien MF, Becker C, Eastham JA, Scardino PT, Björk T, Berglund G, Vickers AJ, Lilja H. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. Journal of Clinical Oncology 2008;26:835-841.

Veselis RA, Pryor KO, Reinsel RA, Li Y, Mehta M, Johnson Jr. R. Effects of propofol and midazolam on long term memory start soon after encoding - ERP evidence. Anesthesiology 2008; (in press).

Vickers AJ. Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. European Urology 2008;54:802-803.

Vickers AJ, Basch E, Kattan MW. Against diagnosis. Annals of Internal Medicine 2008;149:200-203.

Vickers AJ, Bianco FJ, Gonen M, Cronin AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT. Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. European Urology 2008;53:960-966.

Vickers AJ, Cassileth BR. Living proof and the pseudoscience of alternative cancer treatments. Journal of the Society of Integrative Oncology 2008;6:37-40.

Vickers AJ, Cronin AM, Aus G, Pihl CG, Becker C, Pettersson K, Scardino PT, Hugosson J, Lilja H. A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer; data from the European randomized study of prostate cancer screening in Goteborg, Sweden. BMC Medicine 2008;6:19.

Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Medical Informatics and Decision Making 2008;8:53.

Vickers AJ, Jang K, Sargent D, Lilja H, Kattan MW. Systematic review of statistical methods used in molecular marker studies in cancer. Cancer 2008;112:1862-1868.

Vickers AJ. Basic introduction to research: how not to do research. Journal of the Society of Integrative Oncology 2008;6:82-85.

Vickers AJ. Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers. American Statistician 2008;62:314-320.

Vickers AJ. Do we want more cancer patients on clinical trials If so, what are the barriers to greater accrual? Trials 2008;9:31.

Vickers AV, Elkin EB, Peele PB, Dickler M, Siminoff LA. Long-term health outcomes of a decision aid: Data from a randomized trial of Adjuvant! in women with localized breast cancer. Medical Decision Making 2008; (in press).

Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ. Management and outcomes of post-pancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. Journal of the American College of Surgeons 2008;207:490-498.

Voigt LP, Pastores SM, Raoof ND, Thaler HT, Halpern NA. Intrahospital transport of critically ill patients: outcomes, timing, and patterns. Journal of Intensive Care Medicine 2008; (in press).

Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, Muller RJ, Newcomer LN, O'Brien S, Reinke D, Rubino M, Saltz L, Walters RS. NCCN task force report: oral chemotherapy. Journal of the National Comprehensive Cancer Network 2008; Suppl 3:S1-14. review.

Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD. Individualized prediction of colon cancer recurrence using a nomogram. Journal of Clinical Oncology 2008;26:380-385.

White R, Winston C, Gonen M, D'Angelica M, Jarnagin W, Fong Y, Conlon K, Brennan M, Allen P. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. Journal of the American College of Surgeons 2008;206:445-450.

Zakrzewski JL, Suh D, Markley JC, Smith OM, King C, Goldberg GL, Jenq R, Holland AM, Grubin J, Cabrera-Perez J, Brentjens RJ, Lu SX, Rizzuto G, Sant'Angelo DB, Riviere I, Sadelain M, Heller G, Zúñiga-Pflücker JC, Lu C, van den Brink MR. Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nature Biotechnology 2008;26:453-461.

Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2008;149:659-669.

Zauber AG, Levin TR, Jaffe CC, Galen BA, Ransohoff DF, Brown ML. Implications of new colorectal cancer screening technologies for primary care practice. Medical Care 2008;49:(9 Suppl):S139-146.

Zauderer M, Patil SM, Hurria A. Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast Cancer Research and Treatment 2008; [epub ahead of print].

Zelefsky MJ, Shi W, Yamada Y, Kollmeier M, Cox B, Park J, Seshan V. Post-radiotherapy two-year PSA nadir as a predictor of long-term prostate cancer mortality. International Journal of Radiation Oncology, Biology, Physics 2008;(in press).

Zelefsky MJ, Yamada Y, Fuks Z, Zhang Z, Hunt M, Cahlon O, Park J, Shippy A. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. International Journal of Radiation Oncology Biology Physics 2008;71:1028-1033.

Zhang J, Mironov S, Hricak H, Ishill NM, Moskowitz CS, Soslow RA, Chi DS. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography. Journal of Computer Assisted Tomography 2008;32:533-540.

Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience. Radiology 2008;247:458-64.

Zhang J, Yang X, Yin X, Zhang Z, Fuks Z, Kolesnick R. Downregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotides correlates with tumor drug uptake. Cancer Biology and Therapy 2008;7:1490-1495.

Zhang Z, Mo Q. Biased estimator. Encyclopedia of Research Design 2008;(in press).

Zhang Z, Sun J. Interval censoring. Statistical Methodology for Medical Research 2008;(in press).

Zhang Z. Linear transformation models for interval-censored data: prediction and model checking. Statistical Modeling 2008;(in press).

Zhou P, Comenzo RL, Olshen AB, Bonvini E, Koenig S, Maslak PG, Fleisher M, Hoffman J, Jhanwar S, Young JW, Nimer SD, Boruchov AM. CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy. Blood 2008;111:3403-3406.

Zhou P, Teruya-Feldstein J, Lu P, Fleisher M, Olshen A, Comenzo RL. Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan. Blood 2008;111:549-557.

Zivanovic O, Alektiar KM, Sonoda Y, Zhou Q, Iasonos A, Tew WP, Diaz JP, Chi DS, Barakat RR, Abu-Rustum NR. Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy. Gynecologic Oncology 2008;111:265-270.

Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS.The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic Oncology 2008;108:287-292.

Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube and primary peritoneal cancer. Gynecologic Oncology 2008;108:287-292.

Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Soslow R, Juretzka MM, Chi DS, Barakat RR, Brennan MF, Hensley ML. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the FIGO and AJCC staging systems. Journal of Clinical Oncology 2008; (in press).